Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom

被引：0
|
作者：
A. Svedbom
P. Hadji
E. Hernlund
R. Thoren
E. McCloskey
R. Stad
B. Stollenwerk
机构：
[1] ICON,Centre for Metabolic Bone Diseases
[2] Frankfurt Center of Bone Disease,Centre for Integrated research in Musculoskeletal Ageing (CIMA), Mellanby Centre for Bone Research
[3] Philips-University of Marburg,undefined
[4] University of Sheffield,undefined
[5] University of Sheffield,undefined
[6] Amgen Europe (GmbH),undefined
来源：
Osteoporosis International | 2019年 / 30卷
关键词：
Costs and costs analysis; Cost-benefit analysis; Cost-effectiveness; Osteoporosis; Osteoporotic fracture; Preventive medicine; Practice patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1745 / 1754
页数：9
相关论文
共 50 条
  • [1] Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom
    Svedbom, A.
    Hadji, P.
    Hernlund, E.
    Thoren, R.
    McCloskey, E.
    Stad, R.
    Stollenwerk, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (09) : 1745 - 1754
  • [2] THE COST-EFFECTIVENESS OF BARIATRIC SURGERY IN GERMANY, FRANCE, ITALY AND THE UNITED KINGDOM
    Belarbi, S.
    Kusel, J.
    Thomas, M. G.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A354 - A354
  • [3] Cost-effectiveness of Fosavance® in the treatment and prevention of osteoporosis in the United Kingdom
    Jansen, J.
    Gaugris, S.
    Bergman, G.
    Sen, S. S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S96 - S96
  • [4] COST-EFFECTIVENESS ANALYSIS OF THE EASL 2009 CLINICAL PRACTICE GUIDELINES FOR MANAGEMENT OF CHRONIC HEPATITIS B IN FRANCE, ITALY, PORTUGAL, SPAIN, TURKEY AND THE UNITED KINGDOM
    Vanness, D. J.
    Singfield, C.
    Joseph, I. A.
    van Nooten, F.
    Agarwal, K.
    Buti, M.
    Cakaloglu, Y.
    Marinho, R. T.
    Zarski, J. P.
    Hartz, S.
    De Cock, E.
    Revankar, N.
    Raluy, M.
    Hutt, E.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S398 - S398
  • [5] Cost-effectiveness of fracture prevention in established osteoporosis
    Jonsson, B
    Christiansen, C
    Johnell, O
    Hedbrandt, J
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 30 - 38
  • [6] COST-EFFECTIVENESS OF FRACTURE PREVENTION IN ESTABLISHED OSTEOPOROSIS
    JONSSON, B
    CHRISTIANSEN, C
    JOHNELL, O
    HEDBRANDT, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 1995, 5 (02) : 136 - 142
  • [7] Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: A systematic review
    Tchero, Huidi
    Kangambega, Pauline
    Lin, Lucien
    Mukisi-Mukaza, Martin
    Brunet-Houdard, Solenne
    Briatte, Christine
    Retali, Gerald Reparate
    Rusch, Emmanuel
    [J]. ANNALES D ENDOCRINOLOGIE, 2018, 79 (02) : 67 - 74
  • [8] Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy
    Kim, JJ
    Wright, TC
    Goldie, SJ
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (12) : 888 - 895
  • [9] Cost-effectiveness of fracture prevention in established osteoporosis - Discussion
    Haviko, T
    Sorensen
    Lips, P
    Karlsson, G
    Cooper, C
    Tsakalakos, N
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 39 - 40
  • [10] Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom
    DiBonaventura, Marco daCosta
    Chandran, Arthi
    Hsu, Ming-Ann
    Bushmakin, Andrew
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2013, 5 : 261 - 269
12345